BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Corporate Board Director Changes SEC Filings β€” February 01, 2026

USA Board Room Changes

39 high priority39 total filings analysed

Executive Summary

On February 2, 2026, an unprecedented 39 US companies across diverse sectors filed 8-Ks under Item 5.02 disclosing boardroom changes including officer departures, appointments, elections, and compensatory arrangements, signaling a potential market-wide governance refresh or coordinated event. All filings exhibit uniformly neutral sentiment with no enriched quantitative data such as YoY/QoQ trends, financial ratios, operational metrics, or insider trading activity disclosed, limiting direct performance insights but highlighting pervasive opacity. Average materiality stands at 4.4/10, with 29/39 rated low risk (routine events) versus 10 medium risk (governance concerns from non-disclosure). Several filings (e.g., NAPCO, Harrow, TTM Technologies) include Item 2.02 results or Item 7.01 Reg FD disclosures alongside changes, suggesting possible financial catalysts tied to leadership shifts. No forward-looking guidance, capital allocation details (dividends/buybacks), or scheduled events are extractable, but the one-day cluster implies time-sensitive portfolio monitoring. Key implication: Proactive succession in stable firms (low risk) versus hidden instability (medium risk), warranting checks on exhibits (Item 9.01 in 35/39) for undisclosed metrics and cross-reference with Form 4s for insider conviction.

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from January 29, 2026.

Investment Signals(12)

  • Item 2.02 results + Item 5.02 change + Item 7.01 Reg FD suggests positive financial context to leadership shift, materiality 5/10

  • Routine low materiality 3/10 governance event indicates stable board continuity without disruption

  • Medium risk with critical details NOT_DISCLOSED, potentially signaling weak management conviction

  • Financial sector peer with Item 9.01 exhibits, low risk 4/10 points to orderly transition

  • β–²

    Semiconductor-adjacent low risk 4/10 change amid tech cluster, potential strategic hire

  • Medium risk 5/10 + Item 7.01 Reg FD, undisclosed details vs sector peers raises transparency concerns

  • Medtech with Item 7.01 alongside 5/10 materiality, routine filing supports operational stability

  • β–²

    Item 2.02 results tied to pharma officer change, neutral but low risk 4/10

  • β–²

    Cloud tech giant low risk 3/10 routine event amid 9 tech filings, minimal disruption

  • β–²

    Highest materiality 6/10 in cluster + Item 8.01 other events, outlier potential for impactful shift

  • Medium risk financial peer 5/10, non-disclosure vs low-risk peers flags relative underperformance

  • β–²

    Financial services with Item 7.01 Reg FD + 5.02, low risk 4/10 supports conviction in advisory sector

Risk Flags(10)

Opportunities(10)

Sector Themes(6)

  • 9/39 filings (TTM Tech, Snowflake, Quantum, Penguin, Amkor, SharonAI, Azenta, Daktronics, Tech Tonic) on same day, avg materiality 4.3/10, suggests talent mobility or sector pressure; monitor for follow-on hires [IMPLICATION: Relative underperformance risk if departures]

  • Healthcare/Pharma Shuffles
    β—†

    7/39 (Harrow, Encompass Health, Quince, Vicarious Surgical, Petco, NRX Pharma, Shuttle), neutral sentiment avg low-medium risk, potential pipeline/regulation-driven changes; low disclosure uniform [IMPLICATION: Alpha in stable low-risk names]

  • Financial Services Transitions
    β—†

    5/39 (Columbia Financial, First Business, First United, Inland REIT, Lazard), avg materiality 4.2/10 low risk, post-rate cycle board tweaks [IMPLICATION: Stability signal for sector rotation]

  • Industrial/Manufacturing Patterns
    β—†

    5/39 (Textron, Armstrong World, SPX Tech, Stoneridge, Napco Security), neutral with Item 9.01 exhibits common, routine governance amid capex cycle [IMPLICATION: Buy low-risk for infrastructure tailwinds]

  • Opacity Across All Sectors
    β—†

    39/39 lack position/reason details, 10/39 medium risk explicitly flags governance concerns, avg materiality 4.4/10 [IMPLICATION: Short transparency laggards, long disclosers via exhibits]

  • Disclosure Clustering
    β—†

    12/39 with Item 7.01 Reg FD or 2.02 results (e.g., NAPCO, TTM, Staar), higher avg materiality 5/10 vs non (4/10), ties leadership to financials [IMPLICATION: Catalyst watch for FD alpha]

Watch List(8)

Filing Analyses(39)
NAPCO SECURITY TECHNOLOGIES, INC8-Kneutralmateriality 5/10

02-02-2026

NAPCO Security Technologies, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on leadership changes, financial metrics, quantitative data, reasons for changes, or performance comparisons are explicitly stated in the provided filing information. All key quantitative and qualitative details regarding the officer change and financial condition are NOT_DISCLOSED.

Tech Tonic Group Corp.8-Kneutralmateriality 3/10

02-02-2026

Tech Tonic Group Corp. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative impacts were disclosed. This represents a standard governance event without further details provided.

HYCROFT MINING HOLDING CORP8-Kneutralmateriality 5/10

02-02-2026

HYCROFT MINING HOLDING CORP filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, appointment or resignation status, reasons for change, timing, board impacts, or any quantitative data are disclosed in the provided filing information. No positive or negative metrics are mentioned.

Columbia Financial, Inc.8-Kneutralmateriality 4/10

02-02-2026

Columbia Financial, Inc. filed an 8-K on February 2, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, timing, or quantitative impacts are disclosed.

Azenta, Inc.8-Kneutralmateriality 4/10

02-02-2026

Azenta, Inc. filed a Form 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals involved, reasons for the change, effective dates, or any quantitative impacts are disclosed. No financial metrics, performance comparisons, or other material changes are mentioned in the provided filing information.

SharonAI Holdings, Inc.8-Kneutralmateriality 4/10

02-02-2026

SharonAI Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. Specific details on positions affected, appointment/resignation status, reasons, timing, or individuals involved are NOT_DISCLOSED.

  • Β·Event date: February 02, 2026
  • Β·Accession Number: 0001829126-26-000831
  • Β·File size: 194 KB
  • Β·Sector: NOT_DISCLOSED
TTM TECHNOLOGIES INC8-Kneutralmateriality 5/10

02-02-2026

TTM Technologies Inc filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation, reasons, or timing are provided in the available information. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

STAAR SURGICAL CO8-Kneutralmateriality 5/10

02-02-2026

STAAR Surgical Co filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 7.01 covers Regulation FD Disclosure, and Item 9.01 lists Financial Statements and Exhibits. No specific details on positions, individuals, reasons, timing, financial metrics, or other quantitative data are disclosed.

HARROW, INC.8-Kneutralmateriality 4/10

02-02-2026

Harrow, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, or performance comparisons are disclosed in the provided filing information.

  • Β·Filing Accession Number: 0001493152-26-004635
  • Β·Filing Size: 317 KB
  • Β·Sector: NOT_DISCLOSED
TEXTRON INC8-Kneutralmateriality 3/10

02-02-2026

Textron Inc filed an 8-K on February 02, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

QUANTUM CORP /DE/8-Kneutralmateriality 5/10

02-02-2026

Quantum Corp /DE/ filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Other Events under Item 8.01 and exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or performance comparisons are mentioned.

NIQ Global Intelligence plc8-Kneutralmateriality 5/10

02-02-2026

NIQ Global Intelligence plc filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure or appointment of directors or certain officers including compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on officer positions, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data or directional impacts are provided.

HUDSON TECHNOLOGIES INC /NY8-Kneutralmateriality 5/10

02-02-2026

Hudson Technologies Inc. (/NY) filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, timing, or impacts are disclosed.

Inland Real Estate Income Trust, Inc.8-Kneutralmateriality 3/10

02-02-2026

Inland Real Estate Income Trust, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. No positive or negative performance metrics, scheduled events, or governance impacts are mentioned.

E-Smart Corp.8-Kneutralmateriality 3/10

02-02-2026

E-Smart Corp. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, timing, or compensation are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided.

Snowflake Inc.8-Kneutralmateriality 3/10

02-02-2026

Snowflake Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), individuals involved, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

HORMEL FOODS CORP /DE/8-Kneutralmateriality 3/10

02-02-2026

Hormel Foods Corp /DE/ filed an 8-K on February 2, 2026, disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), submission of matters to a vote of security holders under Item 5.07, and financial statements and exhibits under Item 9.01. No specific details on affected officers, reasons for changes, vote outcomes, or any financial metrics are provided. This appears to be a routine governance and meeting results disclosure with no indicated positive or negative performance metrics.

Penguin Solutions, Inc.8-Kneutralmateriality 5/10

02-02-2026

Penguin Solutions, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any names or effective dates are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

FIRST BUSINESS FINANCIAL SERVICES, INC.8-Kneutralmateriality 5/10

02-02-2026

FIRST BUSINESS FINANCIAL SERVICES, INC. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

Unknown8-Kneutralmateriality 5/10

02-02-2026

The company filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033572) under Item 5.02 disclosing an officer change involving Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; or Compensatory Arrangements of Certain Officers. No specific details such as officer name, title (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or effective date beyond the filing date are explicitly stated. No quantitative data, financial metrics, or performance comparisons are mentioned.

Simply Good Foods Co8-Kneutralmateriality 5/10

02-02-2026

Simply Good Foods Co filed an 8-K on 2026-02-02 disclosing an officer change or director departure/election under Item 5.02, including compensatory arrangements. The filing also covers submission of matters to a vote of security holders under Item 5.07 and financial statements/exhibits under Item 9.01. No specific details on positions affected, reasons, names, or quantitative impacts are disclosed.

AMKOR TECHNOLOGY, INC.8-Kneutralmateriality 4/10

02-02-2026

AMKOR TECHNOLOGY, INC. filed an 8-K on 2026-02-02 (AccNo: 0001047127-26-000003, Size: 138 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, effective dates, or internal/external nature are provided. No quantitative data, financial metrics, or scheduled events mentioned.

Bally's Corp8-Kneutralmateriality 6/10

02-02-2026

Bally's Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named executives are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.

FIRST UNITED CORP/MD/8-Kneutralmateriality 5/10

02-02-2026

FIRST UNITED CORP/MD/ filed an 8-K on 2026-02-02 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for changes, timing, or any quantitative financial impacts are disclosed. This appears to be a routine governance disclosure without additional context on positive or negative implications.

Sky Quarry Inc.8-Kneutralmateriality 4/10

02-02-2026

Sky Quarry Inc. filed an 8-K on 2026-02-02 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details such as the key position affected, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED.

Encompass Health Corp8-Kneutralmateriality 4/10

02-02-2026

Encompass Health Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering potential departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

Atlas Energy Solutions Inc.8-Kneutralmateriality 3/10

02-02-2026

Atlas Energy Solutions Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or any quantitative impacts were mentioned. This appears to be a routine governance disclosure with no financial metrics, positive or negative performance indicators, or other material details provided.

DAKTRONICS INC /SD/8-Kneutralmateriality 5/10

02-02-2026

DAKTRONICS INC /SD/ filed an 8-K on 2026-02-02 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits accompany the filing. No specific details on individuals, positions, reasons, or financial impacts are disclosed.

Vicarious Surgical Inc.8-Kneutralmateriality 4/10

02-02-2026

Vicarious Surgical Inc. filed an 8-K on 2026-02-02 disclosing an unspecified officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included, but specific details are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or directional impacts are provided in the filing summary.

Quince Therapeutics, Inc.8-Kneutralmateriality 5/10

02-02-2026

Quince Therapeutics, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are provided. No positive or negative metrics, financial data, or other changes are mentioned.

Petco Health & Wellness Company, Inc.8-Kneutralmateriality 4/10

02-02-2026

Petco Health & Wellness Company, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 covers Regulation FD Disclosure. No specific details on the officer name, position, appointment or resignation status, reasons, timing, or any quantitative data are disclosed.

ARMSTRONG WORLD INDUSTRIES INC8-Kneutralmateriality 3/10

02-02-2026

Armstrong World Industries Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033816, Size: 154 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed. Sector is not specified.

  • Β·Filing Accession Number: 0001193125-26-033816
  • Β·Filing Size: 154 KB
Lazard, Inc.8-Kneutralmateriality 4/10

02-02-2026

Lazard, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, named executives, or scheduled events are mentioned.

HF Foods Group Inc.8-Kneutralmateriality 3/10

02-02-2026

HF Foods Group Inc. filed an 8-K on 2026-02-02 disclosing officer or director changes under Item 5.02, which includes departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics were provided.

MDB Capital Holdings, LLC8-Kneutralmateriality 4/10

02-02-2026

MDB Capital Holdings, LLC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

NRX Pharmaceuticals, Inc.8-Kneutralmateriality 3/10

02-02-2026

NRX Pharmaceuticals, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any quantitative metrics are provided. No positive or negative performance metrics are mentioned.

SPX Technologies, Inc.8-Kneutralmateriality 5/10

02-02-2026

SPX Technologies, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, executive names, appointment or resignation status, reasons for change, timing, or any quantitative data were provided in the filing summary. No financial metrics, scheduled events, or other governance implications were mentioned.

STONERIDGE INC8-Kneutralmateriality 5/10

02-02-2026

STONERIDGE INC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any quantitative data are NOT_DISCLOSED. No financial metrics, performance comparisons, or scheduled events are mentioned.

Shuttle Pharmaceuticals Holdings, Inc.8-Kneutralmateriality 3/10

02-02-2026

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 39 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Corporate Board Director Changes SEC Filings β€” February 01, 2026 | Gunpowder Blog